Medical Economics October 16, 2020
Payers have been slow to reimburse for preventive care. Is that changing?
Most health care industry stakeholders consider many options in preventive care to be a good investment, shown to improve health and quality of life while also delivering short- and long-term cost savings for health care systems. But even as many new products and strategies in preventive care have been introduced in recent years, payer adoption and reimbursement for these options is often limited, creating challenges for health care systems and entire communities working to expand strategies in disease prevention.
Our Life Sciences Practice team at CRA recently conducted an analysis of the most common barriers to payer adoption and investment in preventive care measures....